Trial Profile
An open labeled, randomized, comparative study to evaluate efficacy and safety of fixed dose combination of ceftriaxone + sulbactam (sulbactomax) vs ceftriaxone in patients suffering from various bacterial infections.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Sep 2016
Price :
$35
*
At a glance
- Drugs Ceftriaxone/sulbactam (Primary) ; Ceftriaxone
- Indications Bacterial infections; Bone and joint infections; Meningitis; Otitis media; Postoperative infections; Respiratory tract infections; Septicaemia; Skin infections; Urinary tract infections
- Focus Therapeutic Use
- Sponsors Venus Remedies
- 06 Mar 2010 New trial record